ClearAlpha Technologies’s Novartis NVS Stock Holding History

ClearAlpha Technologies’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$571K	Buy	+3,735	New	+$573K	1.17%	30

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearAlpha Technologies's NVS Position: Q1 2026 in Review

ClearAlpha Technologies opened a new position in Novartis (NVS) in Q1 2026: 3,735 shares worth $571K. The stake represents 1.17% of the portfolio and ranks #30 among its holdings.

1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

ClearAlpha Technologies held 3,735 shares of Novartis worth $571K as of Q1 2026.
Novartis was a new ClearAlpha Technologies position in Q1 2026.
Novartis made up 1.17% of ClearAlpha Technologies's portfolio in Q1 2026, its #30 holding.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on ClearAlpha Technologies's 13F filing for Q1 2026, filed 15 May 2026.